Observational study of elinzanetant for menopause symptoms
Part of Hormones & metabolism, Women’s health & pregnancy clinical trials.
This study looks at how women use a newer medicine called elinzanetant to manage hot flashes and night sweats from menopause. It's an observational study, meaning you'll continue your regular care while sharing how you're feeling through online surveys.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman going through menopause and experiencing hot flashes or night sweats.
- You are just starting treatment with a new medication called elinzanetant, or have recently started it.
- You agree to sign a consent form that explains the study.
- You are willing to use a computer or smartphone to fill out questionnaires about your symptoms.
- You are not taking part in any other research study that involves experimental treatments.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how the body handles two different forms of a drug called elinzanetant in healthy women. It helps doctors understand the drug's effects and may guide future treatment options.
This study follows women in Canada who are starting fezolinetant, a new medication for hot flashes during menopause. Researchers will track how well it works and how you feel while using it in your regular doctor's care.
This study looks at how hot flashes in midlife women might be connected to heart disease risk. Researchers want to see if managing hot flashes can improve heart health.
This study tests whether fezolinetant, a new medication, can reduce moderate-to-severe hot flashes and night sweats during menopause while protecting heart and brain health. Participants will receive the study drug or placebo and have regular check-ups including brain imaging.
This study tests whether using a virtual-reality headset at home can help reduce hot flashes and night sweats in midlife women. You would use the VR system weekly for 8 weeks to see if it improves your symptoms.
This study tests an oral product to see if it can help with menopause symptoms like hot flashes. It is for women aged 40–65 who still have a uterus and are not on hormone therapy.
Hear when a new Vasomotor Symptoms (VMS) Associated With Menopause trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.